Calmodulin mutations associated with recurrent cardiac arrest in infants

Circulation

Volumn 127, Issue 9, 2013, Pages 1009-1017

  Crotti, Lia ^a,b,c   Johnson, Christopher N ^d   Graf, Elisabeth ^c   De Ferrari, Gaetano M ^a,b   Cuneo, Bettina F ^d,h,i   Ovadia, Marc ^i,j   Papagiannis, John ^k   Feldkamp, Michael D ^d   Rathi, Subodh G ^d   Kunic, Jennifer D ^d   Pedrazzini, Matteo ^b   Wieland, Thomas ^c   Lichtner, Peter ^c   Beckmann, Britt Maria ^l   Clark, Travis ^e   Shaffer, Christian ^f   Benson, D Woodrow ^m,r   Kääb, Stefan ^l,n   Meitinger, Thomas ^c,n,o   Strom, Tim M ^c,o   Chazin, Walter J ^d   Schwartz, Peter J ^a,b,p,q   George, Alfred L ^d,g   more..

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d VANDERBILT UNIVERSITY   (United States)

^e Genome Sciences Resource ^*  (United States)

^f Center for Human Genetics Research   (United States)

^g Institute for Integrative Genomics   (United States)

^h ADVOCATE CHILDREN S HOSPITAL   (United States)

ⁱ ADVOCATE LUTHERAN GENERAL HOSPITAL   (United States)

^j 1120 Science and Engineering Offices   (United States)

^k Mitera Children's Hospital   (Greece)

^l LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^m CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

ⁿ Deutsches Zentrum für Herz Kreislauf Forschung Partner Site   (Germany)

^o TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^p KING SAUD UNIVERSITY   (Saudi Arabia)

^q UNIVERSITY OF CAPE TOWN   (South Africa)

^r MEDICAL COLLEGE OF WISCONSIN   (United States)

more..

Author keywords

arrhythmia; calcium signaling; death, sudden, cardiac; exome

Indexed keywords

CALCIUM; CALCIUM BINDING PROTEIN; CALMODULIN; CALMODULIN 1; CALMODULIN 2; MEXILETINE; PROPRANOLOL; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BLOOD CHEMISTRY; CALCIUM BINDING; COHORT ANALYSIS; CONTROLLED STUDY; DEFIBRILLATION; DEVELOPMENTAL DISORDER; DRUG DOSE INCREASE; EPILEPSY; EXOME SEQUENCING; FEMALE; FOLLOW UP; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; HEART ARREST; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEREDITY; HETEROZYGOSITY; HUMAN; INFANT; LOADING DRUG DOSE; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PARENT; PRIORITY JOURNAL; PROTEIN FOLDING; QT PROLONGATION; RECURRENT DISEASE; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; CALCIUM SIGNALING; CALMODULIN; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GENETIC ASSOCIATION STUDIES; HEART ARREST; HUMANS; INFANT; INFANT, NEWBORN; LONG QT SYNDROME; MALE; MOLECULAR SEQUENCE DATA; MUTATION; PEDIGREE; RECURRENCE;

EID: 84874664698     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.001216     Document Type: Article

References (41)

1. Miller TE, Estrella E, Myerburg RJ, Garcia de Viera J, Moreno N, Rusconi P, Ahearn ME, Baumbach L, Kurlansky P, Wolff G, Bishopric NH. Recurrent third-trimester fetal loss and maternal mosaicism for long-QT syndrome. Circulation. 2004;109:3029-3034.
2. Murphy LL, Moon-Grady AJ, Cuneo BF, Wakai RT, Yu S, Kunic JD, Benson DW, George AL Jr. Developmentally regulated SCN5A splice variant potentiates dysfunction of a novel mutation associated with severe fetal arrhythmia. Heart Rhythm. 2012;9:590-597.
3. Schwartz PJ, Priori SG, Dumaine R, Napolitano C, Antzelevitch C, Stramba-Badiale M, Richard TA, Berti MR, Bloise R. A molecular link between the sudden infant death syndrome and the long-QT syndrome. N Engl J Med. 2000;343:262-267.
4. Ackerman MJ, Siu BL, Sturner WQ, Tester DJ, Valdivia CR, Makielski JC, Towbin JA. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. JAMA. 2001;286:2264-2269.
5. Wang DW, Desai RR, Crotti L, Arnestad M, Insolia R, Pedrazzini M, Ferrandi C, Vege A, Rognum T, Schwartz PJ, George AL Jr. Cardiac sodium channel dysfunction in sudden infant death syndrome. Circulation. 2007;115:368-376.
6. Arnestad M, Crotti L, Rognum TO, Insolia R, Pedrazzini M, Ferrandi C, Vege A, Wang DW, Rhodes TE, George AL Jr, Schwartz PJ. Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. Circulation. 2007;115:361-367.
7. Wang DW, Crotti L, Shimizu W, Pedrazzini M, Cantu F, De Filippo P, Kishiki K, Miyazaki A, Ikeda T, Schwartz PJ, George AL Jr. Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel. Circ Arrhythm Electrophysiol. 2008;1:370-378.
8. Bankston JR, Yue M, Chung W, Spyres M, Pass RH, Silver E, Sampson KJ, Kass RS. A novel and lethal de novo LQT-3 mutation in a newborn with distinct molecular pharmacology and therapeutic response. PLoS ONE. 2007;2:e1258.
9. Schwartz PJ, Priori SG, Bloise R, Napolitano C, Ronchetti E, Piccinini A, Goj C, Breithardt G, Schulze-Bahr E, Wedekind H, Nastoli J. Molecular diagnosis in a child with sudden infant death syndrome. Lancet. 2001;358:1342-1343.
10. Schwartz PJ, Crotti L, Insolia R. Long-QT syndrome: from genetics to management. Circ Arrhythm Electrophysiol. 2012;5:868-877.
11. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754-1760.
12. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, DePristo MA. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297-1303.
13. Cooper GM, Stone EA, Asimenos G, Green ED, Batzoglou S, Sidow A; NISC Comparative Sequencing Program. Distribution and intensity of constraint in mammalian genomic sequence. Genome Res. 2005;15:901-913.
14. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248-249.
15. Ng PC, Henikoff S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003;31:3812-3814.
16. Schwartz PJ, Moss AJ, Vincent GM, Crampton RS. Diagnostic criteria for the long QT syndrome: an update. Circulation. 1993;88:782-784.
17. Vissers LE, de Ligt J, Gilissen C, Janssen I, Steehouwer M, de Vries P, van Lier B, Arts P, Wieskamp N, del Rosario M, van Bon BW, Hoischen A, de Vries BB, Brunner HG, Veltman JA. A de novo paradigm for mental retardation. Nat Genet. 2010;42:1109-1112.
18. O'Roak BJ, Deriziotis P, Lee C, Vives L, Schwartz JJ, Girirajan S, Karakoc E, Mackenzie AP, Ng SB, Baker C, Rieder MJ, Nickerson DA, Bernier R, Fisher SE, Shendure J, Eichler EE. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet. 2011;43:585-589.
19. Fischer R, Koller M, Flura M, Mathews S, Strehler-Page MA, Krebs J, Penniston JT, Carafoli E, Strehler EE. Multiple divergent mRNAs code for a single human calmodulin. J Biol Chem. 1988;263:17055-17062.
20. Chattopadhyaya R, Meador WE, Means AR, Quiocho FA. Calmodulin structure refined at 1.7 A resolution. J Mol Biol. 1992;228:1177-1192.
21. Nelson MR, Chazin WJ. An interaction-based analysis of calciuminduced conformational changes in Ca2+ sensor proteins. Protein Sci. 1998;7:270-282.
22. Bunick CG, Nelson MR, Mangahas S, Hunter MJ, Sheehan JH, Mizoue LS, Bunick GJ, Chazin WJ. Designing sequence to control protein function in an EF-hand protein. J Am Chem Soc. 2004;126:5990-5998.
23. VanScyoc WS, Sorensen BR, Rusinova E, Laws WR, Ross JB, Shea MA. Calcium binding to calmodulin mutants monitored by domainspecific intrinsic phenylalanine and tyrosine fluorescence. Biophys J. 2002;83:2767-2780.
24. Chin D, Means AR. Calmodulin: a prototypical calcium sensor. Trends Cell Biol. 2000;10:322-328.
25. Halling DB, Aracena-Parks P, Hamilton SL. Regulation of voltage-gated Ca2+ channels by calmodulin. Sci STKE. 2006;381:er1.
26. Maier LS, Bers DM, Brown JH. Calmodulin and Ca2+/calmodulin kinases in the heart: physiology and pathophysiology. Cardiovasc Res. 2007;73:629-630.
27. Burgoyne RD. Neuronal calcium sensor proteins: generating diversity in neuronal Ca2+ signalling. Nat Rev Neurosci. 2007;8:182-193.
28. Zhang M, Tanaka T, Ikura M. Calcium-induced conformational transition revealed by the solution structure of apo calmodulin. Nat Struct Biol. 1995;2:758-767.
29. Nadkarni VM, Larkin GL, Peberdy MA, Carey SM, Kaye W, Mancini ME, Nichol G, Lane-Truitt T, Potts J, Ornato JP, Berg RA; National Registry of Cardiopulmonary Resuscitation Investigators. First documented rhythm and clinical outcome from in-hospital cardiac arrest among children and adults. JAMA. 2006;295:50-57.
30. Ortmann L, Prodhan P, Gossett J, Schexnayder S, Berg R, Nadkarni V, Bhutta A; American Heart Association's Get With The Guidelines-Resuscitation Investigators. Outcomes after in-hospital cardiac arrest in children with cardiac disease: a report from Get With The Guidelines-Resuscitation. Circulation. 2011;124:2329-2337.
31. Zühlke RD, Pitt GS, Deisseroth K, Tsien RW, Reuter H. Calmodulin supports both inactivation and facilitation of L-type calcium channels. Nature. 1999;399:159-162.
32. Peterson BZ, DeMaria CD, Adelman JP, Yue DT. Calmodulin is the Ca2+ sensor for Ca2+-dependent inactivation of L-type calcium channels. Neuron. 1999;22:549-558.
33. Alseikhan BA, DeMaria CD, Colecraft HM, Yue DT. Engineered calmodulins reveal the unexpected eminence of Ca2+ channel inactivation in controlling heart excitation. Proc Natl Acad Sci USA. 2002;99:17185-17190.
34. Shamgar L, Ma L, Schmitt N, Haitin Y, Peretz A, Wiener R, Hirsch J, Pongs O, Attali B. Calmodulin is essential for cardiac IKS channel gating and assembly: impaired function in long-QT mutations. Circ Res. 2006;98:1055-1063.
35. Ciampa EJ, Welch RC, Vanoye CG, George AL Jr. KCNE4 juxtamembrane region is required for interaction with calmodulin and for functional suppression of KCNQ1. J Biol Chem. 2011;286:4141-4149.
36. Kim J, Ghosh S, Liu H, Tateyama M, Kass RS, Pitt GS. Calmodulin mediates Ca2+ sensitivity of sodium channels. J Biol Chem. 2004;279:45004-45012.
37. Shah VN, Wingo TL, Weiss KL, Williams CK, Balser JR, Chazin WJ. Calcium-dependent regulation of the voltage-gated sodium channel hH1: intrinsic and extrinsic sensors use a common molecular switch. Proc Natl Acad Sci USA. 2006;103:3592-3597.
38. Potet F, Chagot B, Anghelescu M, Viswanathan PC, Stepanovic SZ, Kupershmidt S, Chazin WJ, Balser JR. Functional Interactions between distinct sodium channel cytoplasmic domains through the action of calmodulin. J Biol Chem. 2009;284:8846-8854.
39. Sarhan MF, Tung CC, Van Petegem F, Ahern CA. Crystallographic basis for calcium regulation of sodium channels. Proc Natl Acad Sci USA. 2012;109:3558-3563.
40. Anderson ME. Multiple downstream proarrhythmic targets for calmodulin kinase II: moving beyond an ion channel-centric focus. Cardiovasc Res. 2007;73:657-666.
41. Nyegaard M, Overgaard MT, Søndergaard MT, Vranas M, Behr ER, Hildebrandt LL, Lund J, Hedley PL, Camm AJ, Wettrell G, Fosdal I, Christiansen M, Børglum AD. Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death. Am J Hum Genet. 2012;91: 703-712.